Maobin Kuang

1.3k citations
52 papers · 703 indexed · h-index 15
Topics
Liver Disease Diagnosis and Treatment (29 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers)Diet, Metabolism, and Disease (15 papers)
Partner nations
ChinaUnited States

In The Last Decade

Maobin Kuang

45 papers receiving 698 citations

Peers

Maobin Kuang
Comparison fields: 5 of 63
  • Endocrinology, Diabetes and Metabolism 381
  • Epidemiology 360
  • Cardiology and Cardiovascular Medicine 163
  • Surgery 125
  • Physiology 112
Replace Akihiro Obora with:
Akihiro Obora Japan
Lilin Gong China
Mi Hae Seo South Korea
Zhenya Song China
Abbas Al‐Kurd Israel
Parjeet Kaur India
M. Tonoli Italy
Marcelo Aizpurúa Argentina
Laura Sánchez‐Íñigo Spain
Cecilie Wium Norway
Maobin Kuang relative to Akihiro Obora Japan Akihiro Obora's profile →
Citations per field
00.5×
Akihiro Obora · 1×
Citations per year

Countries citing papers authored by Maobin Kuang

Since Specialization
Citations

This map shows the geographic impact of Maobin Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maobin Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maobin Kuang more than expected).

Fields of papers citing papers by Maobin Kuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maobin Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maobin Kuang. The network helps show where Maobin Kuang may publish in the future.

Co-authorship network of co-authors of Maobin Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Maobin Kuang. A scholar is included among the top collaborators of Maobin Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maobin Kuang. Maobin Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 4
5 5
6 8
7 9
8 5
9 1
10 4
11 3
12 33
13 42
14 9
15 2
16 52
17 88
18 10
19 126
20 50

About Maobin Kuang

Maobin Kuang is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 52 papers that have together received 703 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers) and Diet, Metabolism, and Disease (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (381 citations), Epidemiology (360 citations) and Hepatology (75 citations). Maobin Kuang has collaborated with scholars based in China and United States. Frequent co-authors include Yang Zou, Guotai Sheng, Song Lu, Ruijuan Yang, Yanjia Zhong, Nan Peng, Shuhua Zhang, Chong Hu, Jiajun Qiu and Guobo Xie. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Translational Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026